المؤلفون: Tiddens H.A., Mott L., Gerbrands K., Graniel K., Kidd T.J., Ramsay K.A., Vidmar S., Carlin J.B., Bell S.C., Wainwright C.E., Grimwood K., Francis P.W., Dakin C., Cheney J., George N., Robertson C.F., Moodie M., Carzino R., Carter R., Armstrong D.S., Cooper P.J., McKay K., Martin A.J., Whitehead B., Hunter J., Byrnes C.A.

مصطلحات الفهرس: tobramycin/ih [Inhalational Drug Administration], tobramycin/iv [Intravenous Drug Administration], timentin/iv [Intravenous Drug Administration], antibiotic therapy, article, bacterial strain, bacterium culture, bacterium isolate, child, chronotherapy, cystic fibrosis, eradication therapy, female, genotype, human, intervention study, longitudinal study, lower respiratory tract, lung lavage, major clinical study, male, nonhuman, oropharynx, preschool child, prescription, Pseudomonas aeruginosa, Pseudomonas infection/dt [Drug Therapy], randomized controlled trial (topic), secondary analysis, upper respiratory tract, ceftazidime/cb [Drug Combination], ceftazidime/dt [Drug Therapy], ceftazidime/iv [Intravenous Drug Administration], ciprofloxacin/dt [Drug Therapy], ciprofloxacin/po [Oral Drug Administration], prescription drug/dt [Drug Therapy], prescription drug/po [Oral Drug Administration], timentin/cb [Drug Combination], timentin/dt [Drug Therapy], tobramycin/cb [Drug Combination], tobramycin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40620
Journal of Cystic Fibrosis
Click here for full text options
LibKey Link

المؤلفون: Tiddens H.A., Mott L., Gerbrands K., Graniel K., Kidd T.J., Ramsay K.A., Vidmar S., Carlin J.B., Bell S.C., Wainwright C.E., Grimwood K., Francis P.W., Dakin C., Cheney J., George N., Robertson C.F., Moodie M., Carzino R., Carter R., Armstrong D.S., Cooper P.J., McKay K., Martin A.J., Whitehead B., Hunter J., Byrnes C.A.

مصطلحات الفهرس: tobramycin/ih [Inhalational Drug Administration], tobramycin/iv [Intravenous Drug Administration], timentin/iv [Intravenous Drug Administration], antibiotic therapy, article, bacterial strain, bacterium culture, bacterium isolate, child, chronotherapy, cystic fibrosis, eradication therapy, female, genotype, human, intervention study, longitudinal study, lower respiratory tract, lung lavage, major clinical study, male, nonhuman, oropharynx, preschool child, prescription, Pseudomonas aeruginosa, Pseudomonas infection/dt [Drug Therapy], randomized controlled trial (topic), secondary analysis, upper respiratory tract, ceftazidime/cb [Drug Combination], ceftazidime/dt [Drug Therapy], ceftazidime/iv [Intravenous Drug Administration], ciprofloxacin/dt [Drug Therapy], ciprofloxacin/po [Oral Drug Administration], prescription drug/dt [Drug Therapy], prescription drug/po [Oral Drug Administration], timentin/cb [Drug Combination], timentin/dt [Drug Therapy], tobramycin/cb [Drug Combination], tobramycin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/40620
Journal of Cystic Fibrosis
LibKey Link